SECOND AMENDMENT TO OFFICE LEASE AGREEMENTOffice Lease Agreement • March 5th, 2014 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMarch 5th, 2014 Company IndustryThis SECOND AMENDMENT TO OFFICE LEASE AGREEMENT (“Amendment”), dated for reference purposes as of this 18 day of January, 2011, is by and between EMERYVILLE OFFICE, L.L.C., a Delaware limited liability company (“Landlord”) (as successor-in-interest to NOP WATERGATE LLC, a Delaware limited liability company [“NOP”]), on the one hand, and ADAMAS PHARMACEUTICALS, INC., a Delaware corporation (formerly known as Neuromolecular Pharmaceuticals, Inc.) (“Tenant”), on the other hand, with respect to the following:
SECOND AMENDMENT TO OFFICE LEASE AGREEMENTOffice Lease Agreement • January 31st, 2014 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledJanuary 31st, 2014 Company IndustryThis SECOND AMENDMENT TO OFFICE LEASE AGREEMENT (“Amendment”), dated for reference purposes as of this 18 day of January, 2011, is by and between EMERYVILLE OFFICE, L.L.C., a Delaware limited liability company (“Landlord”) (as successor-in-interest to NOP WATERGATE LLC, a Delaware limited liability company [“NOP”]), on the one hand, and ADAMAS PHARMACEUTICALS, INC., a Delaware corporation (formerly known as Neuromolecular Pharmaceuticals, Inc.) (“Tenant”), on the other hand, with respect to the following: